M1 Macrophage and M1/M2 ratio defined by transcriptomic signatures resemble only part of their conventional clinical characteristics in breast cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
M1 Macrophage and M1/M2 ratio defined by transcriptomic signatures resemble only part of their conventional clinical characteristics in breast cancer
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-10-06
DOI
10.1038/s41598-020-73624-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biologically Aggressive Phenotype and Anti-cancer Immunity Counterbalance in Breast Cancer with High Mutation Rate
- (2020) Hideo Takahashi et al. Scientific Reports
- Accelerated Partial Breast Irradiation: Macrophage Polarisation Shift Classification Identifies High-Risk Tumours in Early Hormone Receptor-Positive Breast Cancer
- (2020) Sören Schnellhardt et al. Cancers
- Lymphovascular invasion in breast cancer is associated with gene expression signatures of cell proliferation but not lymphangiogenesis or immune response
- (2020) Mariko Asaoka et al. BREAST CANCER RESEARCH AND TREATMENT
- G2M Cell Cycle Pathway Score as a Prognostic Biomarker of Metastasis in Estrogen Receptor (ER)-Positive Breast Cancer
- (2020) Masanori Oshi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- High Expression of miR-34a Associated with Less Aggressive Cancer Biology but Not with Survival in Breast Cancer
- (2020) Yoshihisa Tokumaru et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- High Expression of microRNA-143 is Associated with Favorable Tumor Immune Microenvironment and Better Survival in Estrogen Receptor Positive Breast Cancer
- (2020) Yoshihisa Tokumaru et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Overexpression of Murine Rnaset2 in a Colon Syngeneic Mouse Carcinoma Model Leads to Rebalance of Intra-Tumor M1/M2 Macrophage Ratio, Activation of T Cells, Delayed Tumor Growth, and Rejection
- (2020) Annarosaria De Vito et al. Cancers
- A Novel 4-gene Score to Predict Survival, Distant Metastasis and Response to Neoadjuvant Therapy in Breast Cancer
- (2020) Masanori Oshi et al. Cancers
- Immune Cytolytic Activity for Comprehensive Understanding of Immune Landscape in Hepatocellular Carcinoma
- (2020) Hideo Takahashi et al. Cancers
- Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER ‐positive breast cancer
- (2020) Hedda Lippe Gythfeldt et al. INTERNATIONAL JOURNAL OF CANCER
- The role of tumor-associated macrophages in the development, metastasis and treatment of breast cancer
- (2020) Jing Lu et al. PATHOLOGY RESEARCH AND PRACTICE
- Estrogen Receptor Positive Breast Cancer with High Expression of Androgen Receptor has Less Cytolytic Activity and Worse Response to Neoadjuvant Chemotherapy but Better Survival
- (2019) Maiko Okano et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Metabolic reprogramming of macrophages during infections and cancer
- (2019) Shiyao Wang et al. CANCER LETTERS
- Prognostic and predictive role of tumour-associated macrophages in HER2 positive breast cancer
- (2019) Tiia J. Honkanen et al. Scientific Reports
- Immune Profiles of Tumor Microenvironment and Clinical Prognosis among Women with Triple-Negative Breast Cancer
- (2019) Ling Deng et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Triple-Negative Breast Cancer with High Levels of Annexin A1 Expression Is Associated with Mast Cell Infiltration, Inflammation, and Angiogenesis
- (2019) Maiko Okano et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- APOBEC3-Mediated RNA Editing in Breast Cancer is Associated with Heightened Immune Activity and Improved Survival
- (2019) Mariko Asaoka et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Current status and limitations of immunotherapy for breast cancer
- (2019) Yoshihisa Tokumaru et al. SURGERY
- Tumor Infiltrating Lymphocytes and Macrophages Improve Survival in Microsatellite Unstable Colorectal Cancer
- (2019) Sumana Narayanan et al. Scientific Reports
- Late recurrence of breast cancer is associated with pro-cancerous immune microenvironment in the primary tumor
- (2019) Takashi Takeshita et al. Scientific Reports
- High MYC mRNA Expression Is More Clinically Relevant than MYC DNA Amplification in Triple-Negative Breast Cancer
- (2019) Eriko Katsuta et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cytolytic Activity Score to Assess Anticancer Immunity in Colorectal Cancer
- (2018) Sumana Narayanan et al. ANNALS OF SURGICAL ONCOLOGY
- The Immune Landscape of Cancer
- (2018) Vésteinn Thorsson et al. IMMUNITY
- Macrophages: The Road Less Traveled, Changing Anticancer Therapy
- (2018) Jennifer L. Guerriero TRENDS IN MOLECULAR MEDICINE
- High expression of SLCO2B1 is associated with prostate cancer recurrence after radical prostatectomy
- (2018) Tomoaki Terakawa et al. Oncotarget
- Macrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders?
- (2018) Luca Parisi et al. Journal of Immunology Research
- Tumor-associated macrophages in breast cancer: Innocent bystander or important player?
- (2018) Si-Qi Qiu et al. CANCER TREATMENT REVIEWS
- The human RNASET2 protein affects the polarization pattern of human macrophages in vitro
- (2018) Debora Scaldaferri et al. IMMUNOLOGY LETTERS
- Expression of MicroRNA-9 is Associated With Overall Survival in Breast Cancer Patients
- (2018) Judith C. Sporn et al. JOURNAL OF SURGICAL RESEARCH
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reversing the polarization of tumor-associated macrophages inhibits tumor metastasis
- (2017) Rufei Yuan et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Mass cytometry deep phenotyping of human mononuclear phagocytes and myeloid-derived suppressor cells from human blood and bone marrow
- (2017) Mikael Roussel et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Tumour-associated macrophages as treatment targets in oncology
- (2017) Alberto Mantovani et al. Nature Reviews Clinical Oncology
- Tamoxifen sensitivity-related microRNA-342 is a useful biomarker for breast cancer survival
- (2017) Jessica Young et al. Oncotarget
- The interaction of anticancer therapies with tumor-associated macrophages
- (2015) Alberto Mantovani et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
- (2014) Peter J. Murray et al. IMMUNITY
- Tumor-Associated Macrophages: From Mechanisms to Therapy
- (2014) Roy Noy et al. IMMUNITY
- Tumor-associated macrophages: functional diversity, clinical significance, and open questions
- (2013) Subhra K. Biswas et al. Seminars in Immunopathology
- The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients
- (2012) Catharina Medrek et al. BMC CANCER
- GSTP1 expression predicts poor pathological complete response to neoadjuvant chemotherapy in ER-negative breast cancer
- (2012) Tomohiro Miyake et al. CANCER SCIENCE
- Macrophage plasticity and polarization: in vivo veritas
- (2012) Antonio Sica et al. JOURNAL OF CLINICAL INVESTIGATION
- TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine ± trastuzumab
- (2011) Stefan Glück et al. BREAST CANCER RESEARCH AND TREATMENT
- A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer
- (2011) Christos Hatzis JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time
- (2010) Junliang Ma et al. BMC CANCER
- Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome
- (2010) Michael J. Campbell et al. BREAST CANCER RESEARCH AND TREATMENT
- Alternative Activation of Macrophages: An Immunologic Functional Perspective
- (2008) Fernando O. Martinez et al. Annual Review of Immunology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More